What does CUSIP 641288105 represent in this 13F holders report?

CUSIP 641288105 is the security identifier for NPCE - NeuroPace Inc - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

How many institutions held NPCE - NeuroPace Inc - Common Stock, par value $0.001 per share in Q2 2023?

20 institutional investors reported NPCE - NeuroPace Inc - Common Stock, par value $0.001 per share for Q2 2023. Use the holders table for investor-level position and value details.

NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE)

CUSIP: 641288105

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 33,235,472
Total 13F shares: 17,503,080
Share change: -166,990
Total reported value: $78,589,150
Price per share: $4.49
Number of holders: 20
Value change: -$756,243
Number of buys: 8
Number of sells: 9

Quarterly Holders Quick Answers

What is CUSIP 641288105?
CUSIP 641288105 identifies NPCE - NeuroPace Inc - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 641288105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of NPCE - NeuroPace Inc - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Accelmed Partners II L.P.	3/4/5	10%+ Owner	— class O/S missing	4,432,948	$44,878,722	—	21 Nov 2022	3/4/5
KCK LTD.	13F	Company	17%	5,621,111	$26,081,955	—	31 Mar 2023	13F
ORBIMED ADVISORS LLC	13F	Company	12%	4,012,281	$18,616,984	—	31 Mar 2023	13F
Soleus Capital Management, L.P.	13F	Company	7.3%	2,428,714	$11,269,233	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	6.8%	2,258,016	$10,477,194	—	31 Mar 2023	13F
FMR LLC	13F	Company	4.5%	1,492,931	$6,927,200	—	31 Mar 2023	13F
Michael Favet	3/4/5	Chief Executive Officer, Director	— class O/S missing	407,080	$4,121,237	—	21 Feb 2023	3/4/5
MILLENNIUM MANAGEMENT LLC	13F	Company	2.2%	731,610	$3,395,000	—	31 Mar 2023	13F
Nantahala Capital Management, LLC	13F	Company	1.3%	425,925	$1,976,292	—	31 Mar 2023	13F
Irina Ridley	3/4/5	Chief Legal Officer/Secretary	— class O/S missing	141,139	$1,428,877	—	20 Feb 2023	3/4/5
VANGUARD GROUP INC	13F	Company	0.89%	296,548	$1,375,982	—	31 Mar 2023	13F
Kent Lake Capital LLC	13F	Company	0.38%	127,676	$592,417	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.22%	71,515	$331,829	—	31 Mar 2023	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.16%	51,648	$239,647	—	31 Mar 2023	13F
BlackRock Finance, Inc.	13F	Company	0.1%	32,471	$150,666	—	31 Mar 2023	13F
SG Americas Securities, LLC	13F	Company	0.08%	25,388	$118,000	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	0.07%	22,451	$104,173	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	0.05%	16,171	$75,033	—	31 Mar 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.04%	14,500	$67,000	—	31 Mar 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.04%	14,052	$65,201	—	31 Mar 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.04%	13,016	$60,394	—	31 Mar 2023	13F
Financial Advocates Investment Management	13F	Company	0.03%	10,000	$46,400	—	31 Mar 2023	13F
UBS Group AG	13F	Company	0.01%	2,623	$12,171	—	31 Mar 2023	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	784	$4,000	—	31 Mar 2023	13F
BerganKDV Wealth Management, LLC	13F	Company	0%	420	$1,949	—	31 Mar 2023	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	219	$1,016	—	31 Mar 2023	13F
BARCLAYS PLC	13F	Company	0%	118	$548	—	31 Mar 2023	13F
Evan Norton	3/4/5	Director	— class O/S missing	21,698	—	—	21 Apr 2021	3/4/5
Greg Shaw Garfield	3/4/5	Director	— class O/S missing	18,253	—	—	13 Jun 2022	3/4/5

Institutional Holders of NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE) as of Q2 2023

As of 30 Jun 2023, NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE) was held by 20 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 17,503,080 shares. The largest 10 holders included KCK LTD., ORBIMED ADVISORS LLC, Soleus Capital Management, L.P., MORGAN STANLEY, FMR LLC, MILLENNIUM MANAGEMENT LLC, Nantahala Capital Management, LLC, VANGUARD GROUP INC, Kent Lake Capital LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 21 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Q2 2023 holders

Holder diff

-4

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.